New
HealthMore in Health→
THC Trial Cuts PTSD Nightmares in 10-Week Study
Key Takeaways
- A randomized controlled trial found dronabinol reduced nightmare frequency and intensity in adults with PTSD.
- The study assigned 171 patients to dronabinol or placebo for 10 weeks of bedtime treatment.
- Serious adverse events occurred in seven patients on dronabinol and none on placebo.
- The authors said long-term efficacy and safety still need further evaluation.
DE
DT Editorial Team··via nature.com